abstract |
The present invention relates to a prophylactic or therapeutic agent for glomerular diseases comprising an antiplatelet agent and an HMG-CoA reductase inhibitor as active ingredients. The drug is useful for prevention or treatment of various glomerular diseases including chronic glomerulonephritis. |